NRC Health (NRC)
| Market Cap | 563.64M +61.2% |
| Revenue (ttm) | 143.79M +3.4% |
| Net Income | 6.17M -60.6% |
| EPS | 0.27 -62.2% |
| Shares Out | 21.22M |
| PE Ratio | 99.09 |
| Forward PE | 26.83 |
| Dividend | $0.64 (2.41%) |
| Ex-Dividend Date | Dec 29, 2026 |
| Volume | 116,540 |
| Open | 26.88 |
| Previous Close | 26.64 |
| Day's Range | 25.47 - 26.88 |
| 52-Week Range | 11.74 - 27.60 |
| Beta | 0.24 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Oct 27, 2026 |
About NRC
NRC Health provides analytics and insights to measure and improve patient and employee experience for healthcare organizations in the United States. The company offers market experience solutions, a subscription-based services for improved tracking of awareness, perception, and consistency of healthcare brands; assessment of differentiators; and segmentation tools to evaluate the needs, wants, and behaviors of communities through assessments. It also provides patient experience solutions, a cross-continuum multi-mode digital platform that colle... [Read more]
Financial Performance
In 2025, NRC Health's revenue was $137.39 million, a decrease of -3.96% compared to the previous year's $143.06 million. Earnings were $11.29 million, a decrease of -54.43%.
Financial StatementsNews
NRC Health price target raised to $27 from $26 at Citizens
Citizens raised the firm’s price target on NRC Health (NRC) to $27 from $26 and keeps an Outperform rating on the shares. Following the “strong” Q3 results, Citizens tells investors…
NRC Health Earnings Call Transcript: Q3 2026
Q3 revenue rose 11% to $38 million and TRCV grew 9% to $154 million, with adjusted EBITDA margin at 28%. Strong renewals and broad portfolio demand support further Q4 margin progress, tempered by seasonal and implementation timing.
NRC Health Earnings release: Q3 2026
NRC Health released its Q3 2026 earnings on October 27, 2026, summarizing the period's financial results.
NRC Health Quarterly report: Q3 2026
NRC Health has published its Q3 2026 quarterly earnings report on October 27, 2026.
NRC Health reports Q3 adjusted EPS 21c, one estimate 21c
Reports Q3 revenue $38.4M, one estimate $35.8M. “We delivered a strong third quarter, with revenue up 11% year-over-year and sequential margin expansion,” said Trent Green, CEO of NRC Health (NRC).
NRC Health Announces Third Quarter 2026 Results
LINCOLN, Neb.--(BUSINESS WIRE)--NRC Health (NASDAQ: NRC), a leader in healthcare experience improvement solutions, today announced results for the third quarter 2026. “We delivered a strong third quar...
NRC Health Launches nQuire Pro, Extending the Reach of Patient-Experience Teams
LINCOLN, Neb.--(BUSINESS WIRE)-- #HealthcareAccess--NRC Health, a recognized leader in healthcare experience management, today announced the launch of nQuire Pro, a conversational analytics tool desig...
New NRC Health Research Reveals What Sets High-Performing Health Systems Apart: Turning Patient Feedback Into Action
LINCOLN, Neb.--(BUSINESS WIRE)-- #ExperienceManagementEverywhere--Healthcare organizations have more patient feedback, performance dashboards, and experience data at their fingertips than ever before....
NRC Health Announces 2026 Award Winners Recognizing Excellence Across Healthcare
LINCOLN, Neb.--(BUSINESS WIRE)-- #HealthcareConsumerLoyalty--NRC Health today announced the winners of its 2026 awards program, recognizing hospitals, health systems, medical groups, and specialty pro...
Mercy Earns National Honor for Excellence in Patient Experience
Mercy of only three large health systems in the nation to earn distinction Mercy earned NRC Health's 2026 Excellence in Patient Experience Award, marking its fifth consecutive year receiving the natio...
Resideo names Shane Harrison as CFO
Resideo Technologies (REZI) announced that Shane Harrison has been appointed as Resideo’s CFO, effective September 1. He joins Resideo from NRC Health (NRC), a publicly traded healthcare technology an...
NRC Health price target raised to $26 from $23 at Citizens
Citizens raised the firm’s price target on NRC Health (NRC) to $26 from $23 and keeps an Outperform rating on the shares. NRC Health delivered a modest Q2 beat, with…
NRC Health Earnings Call Transcript: Q2 2026
Q2 saw 11% TRCV and 4% revenue growth year-over-year, with strong performance in Experience and The Governance Institute segments. Adjusted EBITDA margin held at 27%, and a landmark customer win began revenue recognition. Market uncertainty persists due to industry consolidation.
NRC Health Earnings release: Q2 2026
NRC Health released its Q2 2026 earnings on July 28, 2026, summarizing the period's financial results.
NRC Health Slides: Q2 2026
NRC Health has posted slides in relation to its Q2 2026 quarterly earnings report, which was published on July 28, 2026.
NRC Health Quarterly report: Q2 2026
NRC Health has published its Q2 2026 quarterly earnings report on July 28, 2026.
NRC Health reports Q2 EPS (15c) vs. (1c) last year
Reports Q2 revenue $35.4M vs. $34.0M last year. “Our second quarter was a success on many fronts, including double-digit TRCV growth over the prior year, strong go-to-market and solutions delivery…
NRC Health Announces Second Quarter 2026 Results
LINCOLN, Neb.--(BUSINESS WIRE)--NRC Health (NASDAQ: NRC), a leader in healthcare experience improvement solutions, today announced results for the second quarter 2026. "Our second quarter was a succes...
AtkinsRéalis submits Notice of Intent to U.S. Nuclear Regulatory Commission for CANDU® reactor licensing
Company begins formal regulatory engagement to bring large-scale nuclear technology to U.S. market amid surging power demand MONTREAL, June 24, 2026 /PRNewswire/ - AtkinsRéalis Group Inc. (TSX: ATRL),...
NRC Health Transcript: AGM 2026
The meeting confirmed quorum and proceeded with the election of seven directors, ratification of KPMG as auditor, approval of executive compensation, and several amendments to the Certificate of Incorporation, all of which passed by shareholder vote.
NRC Health initiated with an Outperform at Citizens
Citizens analyst Constantine Davides initiated coverage of NRC Health (NRC) with an Outperform rating and $23 price target NRC is a leading provider of experience management solutions sold into the…
Georgia's Plant Hatch receives 20-year license renewal from the Nuclear Regulatory Commission
Unit 1 authorized to operate through 2054 and Unit 2 through 2058 ATLANTA, June 15, 2026 /PRNewswire/ -- Georgia Power announced today that the U.S. Nuclear Regulatory Commission (NRC) has approved th...
NRC Health Transcript: 16th Annual East Coast IDEAS Conference
A leading healthcare experience management provider reported strong recurring revenue, robust margins, and a $5B market opportunity. Recent growth is driven by product innovation, AI, and a revamped salesforce, with a major new client set to generate revenue starting July.
NRC Health announces partnership with Healthcare Experience Foundation
NRC Health (NRC) announced a strategic partnership with the Healthcare Experience Foundation to expand the expertise and programs available to help healthcare leaders meet “rising expectations and con...
NRC Health and Healthcare Experience Foundation Launch Strategic Partnership to Deepen Support for Improving Experience, Safety, and Workforce Engagement
LINCOLN, Neb.--(BUSINESS WIRE)-- #HealthcareExperience--Healthcare organizations face rising expectations and constrained resources as they work to improve patient experience, strengthen workforce eng...